Image (0bc4c167 59ce 43ad 9db8 281e4a166887 01)
Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9391
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 0143-9391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (0bc4c167 59ce 43ad 9db8 281e4a166887 02)
This is a graph showing the post-infusion effects of Remifentanil Hydrochloride and Alfentanil. The graph has a time scale (in minutes) on the horizontal axis and an equipotent level on the vertical axis. The equipotent level is a measure of respiratory depression caused by a particular dose of the drug. The graph seems to show that after an initial increase in equipotent level, Remifentanil Hydrochloride causes a significant decrease in respiratory depression compared to Alfentanil.*
Image (0bc4c167 59ce 43ad 9db8 281e4a166887 03)
The text provides a graph with the mean concentration of Affentanil and Remifentanil Hydrochloride at different time intervals. The concentration is measured in nanograms per milliliter. The figure shows that Affentanil was administered to 5 individuals at a dose of 0.5 micrograms per kilogram per minute, while Remifentanil Hydrochloride was administered to 6 individuals at a dose of 0.05 micrograms per kilogram per minute. The graph displays the mean concentration with standard deviation over a period of 480 minutes (8 hours).*
1 mg Vial (0bc4c167 59ce 43ad 9db8 281e4a166887 04)
Remifentanil is a prescription drug administered through injection or intravenous technique. It comes in single-dose vials that need to be discarded if unused. The drug is sterile and requires reconstitution and dilution before use, and the usual dosage should be referred to by checking the insert. The manufacturer distributing it is Hikma, and the product's NDC ID is 0143-9391-01.*
2mg Vial (0bc4c167 59ce 43ad 9db8 281e4a166887 05)
This is a product description for a medication called Remifentanil Hydrochloride, which is for intravenous use only. The medication comes in a single dose vial and must be discarded if any portion remains unused. It is sterile, but must be reconstituted and diluted before use. The recommended dosage is not provided in the description and should be referenced in the product insert. The medication is distributed by Hikma and its National Drug Code (NDC) is 0143-9392-01.*
5mg Vial (0bc4c167 59ce 43ad 9db8 281e4a166887 06)
Remifentanil is a prescription medication that comes in a single dose vial for intravenous use only. The vial contains 9 mg of Remifentanil Hydrochloride Il that must be reconstituted and diluted before use. Any unused portion should be discarded. The usual dosage information can be found in the insert. This medication is sterile and distributed by Hikma from Berkeley Heights in New Jersey. The product code is PAA162770 and the National Drug Code is 0143-9393-01.*
1 mg Carton (0bc4c167 59ce 43ad 9db8 281e4a166887 07)
2 mg Carton (0bc4c167 59ce 43ad 9db8 281e4a166887 08)
5 mg Carton (0bc4c167 59ce 43ad 9db8 281e4a166887 09)
Serialization Image (0bc4c167 59ce 43ad 9db8 281e4a166887 10)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
